Nir Salomon
Founder & Director of the Integrative Gastroenterology unit at Sheba Medical Center. Co-founder and Head of R&D at Evinature.
After founding the Integrative Gastroenterology unit at Sheba Medical Center, Nir Salomon launched a decade-long research project with Professor Shomron Ben-Horin to advance the full potential of nutraceutical therapies for Inflammatory Bowel Disease.
From 2011 to 2022, Salomon led a series of successful trials on the combined use of gut-directed curcumin and Qing Dai (CurQD®) on patients with UC, earning prestigious awards for “breakthrough innovation” and “clinical merit” in his work. His multi-center, international, investigator-initiated placebo-controlled trial on CurQD® was presented at the Crohn’s and Colitis Foundation of America (CCFA), where it was awarded Poster of Distinction.
In 2021, Salomon and Ben-Horin founded Evinature in partnership with Sheba Medical Center to provide affordable, accessible, and clinically-tested, effective therapies to IBD patients.
Salomon lectures worldwide, advocating integrative, evidence-based therapies at prominent medical conferences. He is currently building a global network of leading IBD doctors to facilitate collaborative research projects in the field of nutraceuticals with an aim to advance medical accessibility for patients worldwide.